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CC BY-NC-ND license (http://creativAbstract Background/purpose: With global socioeconomic development and improvement in
the general health care system, life expectancy increases, resulting in an increasing incidence
of end-stage renal disease in the elderly population. We compared the survival rate in elderly
patients aged 65 years with Stage 5 chronic kidney disease, managed with either renal
replacement therapy (RRT) or conservative treatment. We also tried to identify factors asso-
ciated with survival in these two groups.
Methods: This is a single-center retrospective study of patients aged 65 years with Stage 5
chronic kidney disease, who were referred to the nephrology team for renal advance care
planning to assist in decision making for RRT or conservative treatment from 2005 to 2013.
They were followed up till death or till December 31, 2014. Baseline characteristics (demo-
graphics, clinical data, functional status, socioeconomic factors, and laboratory parameters)
and mortality data between the two groups were compared.
Results: A total of 558 patients were recruited during the study period, in which 126 (22.6%) pa-
tients opted for RRTand 432 (77.4%) for conservative treatment. Patients with less significant co-
morbidities, lower modified Charlson’s Comorbidity Index scores, better functional and mental
statuses, as well as better socioeconomic status were more likely to choose RRT. The RRT group
had a longer median survival of 44.6 months compared with 10.0 months in the conservative
treatment group. The survival advantage of theRRT groupwas lost in patients older than 85 years,
or in those with high comorbidity (modified Charlson’s Comorbidity Index score of11) or depen-
dent mobility. Age, comorbidity, and mobility were predictors of mortality in the RRT group. For
the conservative group, age, mobility, and sex were predictors of mortality.
Conclusion: Elderly patients with end-stage renal disease can be benefited from RRT. However,
the survival advantage of RRTwas lost in very-advanced-age patients older than 85 years of age,
in those with high comorbidity, or in functionally dependent patients.of Medicine and Geriatrics, Caritas Medical Centre, 111 Wong Kong Street, Sham Shui Po, Kowloon,
com (W.-H. Kwok).
6.04.002
of Nephrology. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the
ecommons.org/licenses/by-nc-nd/4.0/).
Outcomes in elderly patients with end-stage renal disease 43目的: 在全球性的社會經濟發展下;預期壽命得以延長;導致在老年人口中;末期腎病的發生率亦有
所增長。我們在 65歲的第 5期慢性腎病年老患者間;比較了腎置換療法 (RRT)與保守療法所達到
的存活率。同時;我們亦嘗試找出影響這兩組病人存活的因素。
方法: 這是一項單中心的回溯性研究;對象為  65歲的第 5期慢性腎病患者。他們是在 2005年至
2013 年期間;被轉介至腎科團隊接受預設照顧計劃;以協助他們選擇 RRT 或保守療法；追蹤期至
2014年 12月 31日或病人去世為止。我們比較了兩組病人的基線特徵及死亡率數據。
結果: 本研究共納入 558位病人;其中 126 (22.6%)人選擇了 RRT;432 (77.4%)人選擇了保守療法。
RRT組的存活中位數為 44.6個月;較保守療法組的 10.0個月長。然而;在>85歲、共病顯著 (mCCI
 11)、或不能獨立行動的病人中;RRT的存活優勢消失。在 RRT組中;年齡、共病、及行動力是死
亡的預測因子,在保守療法組中;年齡、行動力、及性別是死亡的預測因子。
結論: 年老末期腎病患者可以獲益於 RRT,然而;在>85歲的極高齡者、共病顯著者、或不能獨立行
動的病人中;RRT的存活優勢不復存在。Introduction
With global socioeconomic development and increasing
prosperity, the living environment and medical care service
have improved over the past decades. The resulting in-
crease in life expectancy, together with lower birth rates
accompanying socioeconomic development, means that
older people are now becoming a larger proportion of the
general population.1 As the estimated glomerular filtration
rate (eGFR) declines in parallel with age,2,3 longer life ex-
pectancy means more elderly patients are reaching end-
stage renal disease. In the United States, the prevalence
of end-stage renal disease continues to increase in all age
groups, with the fastest growing rate among older patients.
Since 2000, the number of end-stage renal disease patients
aged 65e74 years and above 75 years have increased by 30%
and 50%, respectively, in 2012. The prevalence of renal
replacement therapy (RRT) patients aged  75 years
increased from 17.7% in 1992 to 24.5% in 2012.4
In the United Kingdom, the percentage of RRT patients
aged > 70 years increased from 19.2% to 25% between
2000 and 2013.5 In Europe, patients aged  65 years
accounted for 42% of the European RRT population in
2012, with 20% in the age group of 65e74 years and 22% in
75-year age group. China also had a similar increasing
trend, with 18% and 24.2% of the chronic kidney disease
population being among those aged 60e69 years and
70 years, respectively.6,7
Hong Kong is also facing similar challenges with an aging
population. Approximately 95% of patients receiving RRT
were managed by hospitals or dialysis centers of the hos-
pital authority. Owing to the peritoneal dialysis (PD)-first
policy, the number of patients receiving PD had increased
from around 200 in 1985 to more than 3000 in 2006, ac-
counting for three-quarters of the dialysis population
locally in 2011. In the past decade, the median age of pa-
tients on RRT had increased from 56 years to 60 years, with
an increasing prevalence in the age group of >75 years.8e10
Apart from the aging population, more patients with
multiple comorbidities were commenced on RRT. Over 40% of
the patients on dialysis had diabetes mellitus in both the
United States and the United Kingdom. This older patient
group with comorbidities also experiences worse outcomes,
including increased mortality and impaired quality of
life.4,5,11It is often assumed that dialysis is appropriate for all in-
dividuals and improves survival compared with conservative
management. However, it remained controversial in pa-
tients with older age and in those who are more dependent
in daily activities, with multiple comorbidities. In a local
study of 199 elderly patients aged 65 years with Stage 5
chronic kidney disease (CKD), survival was improved by
almost 1.5 years by PD, and the risk of emergency hospi-
talization was halved.12 Dasgupta and Rayner,13 in a retro-
spective study of 129 patients aged > 75 years with Stage 5
CKD, demonstrated that the survival rate had increased 2.9-
fold by dialysis. However, no significant survival advantage
could be demonstrated in patients who were also suffering
from ischemic heart disease, which was common in older
patients. Kurella and colleagues14 also reported that dialysis
in US patients aged 65e79 years and 80e84 years had a
significant median survival of 24.9 months and 15.6 months,
respectively. However, as age advanced, survival benefits
declined. The median survival in very old patients
(85e89 years) was 11.6 months, and 8.4 months for patients
aged  90 years. Moreover, the presence of two to three
comorbid conditions in dialysis patients aged> 65 years was
associated with substantially increased mortality compared
with those with better health.14
Objectives
In this study, we compared the survival rate in elderly pa-
tients aged 65 years with Stage 5 CKD, managed with
either RRT or conservative treatment. We also tried to
identify factors associated with survival in these two groups.Methodology
Study design
This is a single-centered, retrospective cohort study. Pa-
tients with diabetes mellitus or those without diabetes,
followed up at the Caritas Medical Centre, would be
referred to the nephrology team for assessment when their
serum creatinine level was >350 mmol/L or >400 mmol/L,
respectively. A renal advance care planning (ACP) meeting,
including a nephrologist, medical social worker, and patient
and his/her family, would be arranged as soon as the
44 W.-H. Kwok et al.patient’s renal function reached the suggested range, to
assist in decision making regarding RRT or conservative
management. Detailed information and experience would
be explained to the patients and their families during the
ACP interview, and their physical, psychological, and social
concerns would be addressed and discussed during weekly
renal case conference. Patient’s decision would be
confirmed upon next few follow ups, and then the patient
would be referred to either predialysis clinic or palliative
care clinic for regular follow up according to patient’s
treatment modality. Whatever the choices were, multidis-
ciplinary care would be provided by a team of physicians,
specialist nurses, social workers, dietitians, occupational
therapists, and physiotherapists, in order to optimize
medical and sociopsychological management of renal dis-
ease. Telephone hotline would be provided for symptom
control.
In this study, clinical records of all patients aged
65 years or above with Stage 5 CKD (defined as
eGFR  15 mL/min/1.73 m2 using the Modification of Diet
in Renal Disease equation)15 who received ACP over an 8-
year period (from January 1, 2005 to December 31, 2013)
were retrospectively reviewed. The date of study entry
was the date of renal ACP. Late referral was defined as
patients who received either dialysis or palliative care
service within 30 days of ACP. Patients who were referred
out to another hospital after the ACP, those with recovery
of renal function who became dialysis independent during
the study period, or those defaulted follow ups before a
decision was made were excluded from the study. Partic-
ipants were followed up till death, lost to follow up, or
followed up for a minimum of 1 year till the end of the
study on December 31, 2014. They were categorized into
conservative treatment group (defined as those who opted
for conservative management after ACP and received no
dialysis) and renal replacement (RRT) group (defined as
those who made a decision to commence RRT). Their
baseline characteristics and survival outcomes were
studied.Data collection
Data were collected by a retrospective review of comput-
erized records from the Clinical Management System and
from written clinical notes. Baseline characteristics of
participants were recorded during ACP, which are as
follows:
 Demographic data: age and sex
 Clinical data: etiology of CKD and modified Charlson’s
Comorbidity Index (mCCI)16,17
 Mental state at renal ACP
 Functional status (independent walker, assisted walker,
and chairbound or bedridden patients) at ACP
 Socioeconomic factors: marital status, education level,
place of abode, presence of caregiver, and receiving
comprehensive social security allowance
 Modality of dialysis: self-PD, helper PD, hemodialysis
(HD) in a private hospital, HD in a government hospital,
and pre-emptive renal transplant
 Reason for not choosing dialysis Laboratory parameters: serum creatinine, eGFR, so-
dium, potassium, calcium, phosphate, bicarbonate, al-
bumin, and hemoglobin levels
 Time for decision after ACP, death by the end of the
study, any change of decision before death, and causes
of death
Outcomes
Primary outcome was survival (defined as patient survival
from the date of ACP to death or end of the study) be-
tween those who opted for RRT versus those who opted for
conservative treatment. Secondary outcomes included
factors affecting patients’ treatment modality, predicting
factors affecting survival of each group, and the cause of
death.
Statistical analysis
All statistical analyses were performed using Statistical
Package for the Social Science (SPSS; IBM, Hong Kong),
Version 22. Basic descriptive statistics were computed for
the demographic data. Survival outcomes were measured
by KaplaneMeier survival analysis. Chi-square test and
Fisher exact test were used for the categorical variables
and t test and ManneWhitney U test for continuous vari-
ables as appropriate. Cox proportional hazards model
[setting confidence interval (CI) for Exp (B) at 95%] for
predicting factors of mortality. The results were expressed
as percentage (%) or number (n) for categorical variables,
and means  standard deviation or median for continuous
variables.
Results
During the study period, a total of 833 patients
(20e101 years old) with Stage 5 CKD (eGFR  15 mL/min/
1.73 m2) were referred for renal ACP. Five hundred
and sixty patients (67.2%) were aged  65 years. Two
patients defaulted follow ups after the ACP interview,
before a decision was made. They were excluded from
the study. The remaining 558 patients aged 65e101 years
(mean  standard deviation: 78.4  7.0 years) were fol-
lowed up till death or till the end of the study. Among these
patients, 442 (79.2%) decided for conservative care and 116
(20.8%) opted for RRT. None of the patients opted for pre-
emptive renal transplant at that time. The median duration
for patients to make a decision after ACP was 10.0 days
(range 0e42 days).
These patients were followed up regularly by our spe-
cialty teams according to their preference of treatment.
However, 24 (4.3%) patients changed their option for
treatment by the end of the study. Seventeen patients
changed from conservative care to dialysis and seven from
dialysis to conservative care. One of the patients aged
77 years had renal transplant in Mainland China after
2 months of private HD. Hence, the final number of patients
in the conservative group and RRT group became 432
(77.4%) and 126 (22.6%), respectively. Ninety-seven pa-
tients (77%) of the RRT group received PD and 29 (23%)
received HD. Two patients from the RRT group died before
Table 1 Baseline characteristics between the conservative treatment and renal replacement therapy groups.
Baseline characteristics All patients
(n Z 558)a
Conservative group
(n Z 432)a
Renal replacement group
(n Z 126)a
p
Demographics
Age (y) 78.4  7.0 79.6  6.8 74.2  6.1 <0.001
Male (%) 43.7 41.7 50.8 0.07
Female (%) 56.3 58.3 49.2 0.07
Etiology of CKD
Diabetic nephropathy (%) 57.9 57.9 57.9 0.99
Hypertensive nephropathy (%) 13.1 13.7 11.1 0.46
Glomerulonephritis (%) 2.0 1.4 4.0 0.07
Polycystic kidney (%) 0.7 0.5 1.6 0.22
Others (%) 5.6 4.9 7.9 0.19
Unknown (%) 20.8 21.8 17.5 0.30
Comorbidity
mCCI scores 8.7  2.3 9.0  2.3 7.8  2.3 <0.001
Congestive heart failure (%) 25.3 28.5 14.3 <0.001
Stroke (%) 25.6 29.2 13.5 <0.001
Dementia (%) 10.6 13.2 1.6 0.001
Hyperlipidemia (%) 24.9 21.1 38.1 <0.001
Diabetes mellitus (%) 60.2 60.4 59.5 0.86
Ischemic heart disease (%) 29.0 30.6 23.8 0.14
Peripheral vascular disease (%) 4.8 4.4 6.3 0.37
Chronic pulmonary disease (%) 3.4 4.2 0.8 0.07
Liver disease (%) 5.6 5.3 6.3 0.66
Cancer (%) 10.8 11.3 8.7 0.41
Hypertension (%) 87.6 88.0 86.5 0.66
Mobility
Independent walker (%) 43.7 37.5 65.1 <0.001
Assisted walker (%) 37.3 39.8 28.6 0.02
Chairbound/bedridden (%) 19.0 22.7 6.3 <0.001
Mental status
Full (%) 78.1 72.9 96.0 <0.001
Limited (%) 14.7 17.8 4.0 <0.001
Incapacitated (%) 7.2 9.3 0.0 <0.001
Socioeconomic factors
Living with relatives (%) 71.3 66.9 86.5 <0.001
Living in nursing home (%) 15.7 17.1 5.6 <0.001
Living alone (%) 12.2 13.7 7.1 0.05
Living in public housing (%) 55.2 58.0 44.5 0.01
Living in self-owned property (%) 21.1 16.8 37.2 <0.001
Living on own income (%) 2.4 1.7 5.3 0.03
Receiving CSSA (%) 31.3 33.8 21.9 0.02
Illiterate (%) 43.9 49.6 22.9 <0.001
Late referral (%) 34.6 32.9 40.2 0.15
Laboratory parameters
eGFR (mL/min/1.73 m2) 10.0  2.9 10.2  2.8 9.3  3.3 0.01
Hemoglobin (g/dL) 8.7  1.5 8.7  1.5 9.0  1.4 0.02
Calcium (mmol/L) 2.07  0.2 2.1  0.2 2.0  0.3 0.84
Phosphate (mmol/L) 1.7  0.5 1.7  0.4 1.8  0.6 0.08
Albumin (g/L) 29.6  6.1 29.6  6.1 29.5  6.0 0.87
CKD Z chronic kidney disease; CSSA Z comprehensive social security allowance; eGFR Z estimated glomerular filtration rate.
Italics is used to highlight those with p < 0.05.
a Results were expressed as % or mean  standard deviation whenever appropriate.
Outcomes in elderly patients with end-stage renal disease 45dialysis began. Twenty-two patients from the RRT group
received emergency HD before initiating long-term dialysis.
The mean duration from ACP to initiation of RRT was
4.2  1.7 months.Baseline characteristics
Demographics of the 558 patients are given in Table 1. The
conservative group was older (mean age 79.6  6.8 years
Figure 1 Causes of death in patients with Stage 5 chronic
kidney disease in both conservative treatment and renal
replacement therapy groups. ACSZ acute coronary syndrome;
CAPD Z continuous ambulatory peritoneal dialysis;
CHF Z congestive heart failure; CVA Z cardiovascular acci-
dent; ESRF Z end-stage renal failure; RRT Z renal replace-
ment therapy; UGIB Z upper gastrointestinal bleeding.
Figure 2 KaplaneMeier survival curves for patients in
the conservative treatment and RRT groups. (The orange
dashed-dotted lines indicate median survival). ACPZ advance
care planning; Cum Z cumulative; RRT Z renal replacement
therapy.
46 W.-H. Kwok et al.vs. 74.2  6.1 years, p < 0.001), with a higher eGFR
(10.2  2.8 vs. 9.3  3.3, pZ 0.01) and a higher mCCI score
(9.0  2.3 vs. 7.8  2.3, p < 0.001), which included a higher
incidence of congestive heart failure (28.5% vs. 14.3%,
p < 0.001), stroke (29.2% vs. 13.5%, p < 0.001), and de-
mentia (13.2% vs. 1.6%, p < 0.001) compared with the RRT
group. The two groups also differed in their functional and
mental statuses with more independent walkers (65.1% vs.
37.5%, p < 0.001) and mentally fully competent patients
(96.0% vs. 72.9%, p < 0.001) in the RRT group. By contrast,
more assisted walkers (39.8% vs. 28.6%, p Z 0.02) or
chairbound/bedridden patients (22.7% vs. 6.3%, p < 0.001)
and patients with limited mental competence (17.8% vs.
4.0%, p< 0.001) were in the conservative group. Patients
who opted for dialysis were more likely to be living with
relatives (86.5% vs. 66.9%, p < 0.001), had a self-owned
property (37.3% vs. 16.8%, p < 0.001), and living on own
income (5.3% vs. 1.7%, p Z 0.03). Contrarily, those who
opted for conservative management were more likely to be
living in a nursing home (17.1% vs. 5.6%, p < 0.001),
receiving comprehensive social security allowance (33.8%
vs. 21.9%, p Z 0.02), and were uneducated (49.6% vs.
22.9%, p < 0.001). There were no significant differences in
sex, etiology of CKD, incidence of diabetes mellitus,
ischemic heart disease, hypertension, peripheral vascular
disease, and serum calcium, phosphate, and albumin levels
between the two groups.
Causes of death in the dialysis and conservative
groups
In this study, a total of 454 (81.4%) patients died before the
end of the studyd387 from the conservative group (89.6%
of all conservative group patients) and 67 from the RRT
group (53.2% of all RRT group patients). Figure 1 shows the
overall causes of death in both groups of patients. The most
common cause of death in the conservative group was
end-stage renal failure (46.8%), followed by infection
(pneumonia þ other infections Z 22.8%) and
cardiovascular-related causes (i.e., acute coronary syn-
drome þ congestive heart failure) (18.4%). In the RRT
group, infection [pneumonia þ continuous ambulatory
peritoneal dialysis (CAPD) peritonitis þ other infections
Z 32.8%] was the commonest cause of death, in which most
patients died of CAPD peritonitis (14.9%) and pneumonia
accounted for 11.9% of deaths in the RRT group.
Cardiovascular-related disease (28.4%) was the second
commonest cause of death in the RRT group, but acute
coronary syndrome alone (26.9%) was the principle cause of
death.
Survival of RRT and conservative treatment
The RRT group had a longer median survival of
44.6 months (95% CI, 37.3e51.9 months) compared with
10.0 months in the conservative group (95% CI,
8.3e11.7 months) (p < 0.001; Figure 2). Divergence was
seen approximately 60 days after ACP. There was no sig-
nificant survival difference between the PD and HD groups
(p Z 0.55). The RRT group also had a superior 1-year
(78.6% vs. 39.6%), 2-year (54.0% vs. 13.0%), and 5-year
Table 2 One-year, 2-year, and 5-year survival rates of the conservative and RRT groups.
Overall age  65 y Age 65e74 y Age  75 y
Conservative group
(n Z 432)
RRT group
(n Z 126)
All patients
(n Z 558)
Conservative group
(n Z 112)
RRT group
(n Z 69)
Conservative group
(n Z 320)
RRT group
(n Z 57)
1-y survival
rate (%)
39.6 78.6 48.4 48.2 87.0 36.3 66.7
2-y survival
rate (%)
13.0 54.0 22.2 15.2 65.2 11.9 38.6
5-y survival
rate (%)
0.9 11.9 3.4 1.8 15.9 0.3 5.3
RRT Z renal replacement therapy.
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servative group (Table 2).
Survival rate in younger and older age groups
Under subgroup analysis, median survivals of the RRT and
conservative groups, at age 75 years and 85 years, were
32.7 months (95% CI, 21.4e44.0 months) versus 9.1 months
(95% CI, 7.2e11.2 months), and 11.7 months (95% CI,
4.4e19.0 months) versus 5.0 months (95% CI,
3.2e6.8 months), respectively. The RRT group had superior
1-year and 2-year survival rates compared with the con-
servative group (Table 2). The superiority was preserved
even in the older age group, although the differences were
smaller. At the age of 75 years, the 1-year and 2-year
survival rates of the RRT and conservative groups were
66.7% versus 36.3% and 38.6% versus 11.9%, respectively.
Factors associated with survival in the RRT and
conservative treatment groups
The survival advantage was preserved in those receiving
RRT with low comorbidity and an mCCI score of 6
(p < 0.001) or with independent mobility (p < 0.001).
However, the survival benefit was lost when the patient’s
age was 85 years or more (pZ 0.96), when the patient had
high comorbidity with an mCCI score of 11 (pZ 0.087), or
in patients with impaired mobility (pZ 0.22; Figures 3e5).
Under subgroup analysis of very old patients,
aged 85 years, low or high mCCI scores did not show any
significant difference in their survival (p Z 0.18 and
p Z 0.17) (Figure 6). The survival benefit persisted in pa-
tients who were able to walk unaided (p Z 0.04), but was
lost in assisted walkers or chairbound patients (p Z 0.96
and p Z 0.59) (Figure 7). However, only 96 patients were
aged 85 years, with 89 of them from the conservative
group and only seven from the RRT group. The number of
patients was even smaller when they were divided into
subgroups. The three independent walkers aged 85 years
had a cumulative survival of at least 30 months from ACP,
which was longer than we expected.
The survival advantage was preserved in patients of all
age groups who were independent walkers (all with
p < 0.05; Figure 8), but lost in those who were chairbound
(all with p > 0.1; Figure 9). Similarly, a significant survival
advantage was observed in patients who were independent
walkers with an mCCI score of 11 (p < 0.001), but the
advantage was lost in patients with an mCCI score of >11
(pZ 0.42; Figure 10). However, there was only one patientwith an mCCI score of 11 in the RRT group. No significant
survival benefit was observed in either low or high comor-
bidity in patients who were chairbound with mCCI scores of
8 and >8 (p Z 0.10 and p Z 0.77; Figure 11).
In a Cox proportional hazards model, the significant
predictors of mortality in RRT patients were age [Hazard
ratio (HR) 1.05, 95% CI 1.00e1.10, p Z 0.03), mCCI (HR
1.12, 95% CI 1.01e1.24, p Z 0.04), and independent
walker (HR 0.17, 95% CI 0.07e0.40, p < 0.001; Table 3).
This suggested that patients on dialysis who were younger,
with lower comorbidity and independent mobility, were
associated with better outcomes compared with those who
were older with high comorbidity and dependent mobility.
Applying the same model in the conservatively managed
patients produced slightly differing results (Table 4). The
predictors of mortality were age (HR 1.02, 95% CI
1.00e1.03, p Z 0.04), mobilitydwith better survival in
those able who were to walk unaided (HR 0.14, 95% CI
0.07e0.26, p < 0.001) compared with those who were
dependent (HR 0.29, 95% CI 0.15e0.56, p < 0.001), and
sexdfemale patients have a 35% reduced risk compared
with male patients (HR 0.65, 95% CI 0.53e0.80, p < 0.001).
However, mCCI did not reach statistical significance in the
conservative group (p Z 0.66). In this study, diabetes
mellitus (p Z 0.58 vs. p Z 0.45) and ischemic heart dis-
ease (p Z 0.39 vs. p Z 0.08) did not have significant
contribution to mortality in both the conservative and the
RRT group.
Discussion
Older patients with advanced CKD are at higher risks of
death, end-stage renal failure, acute coronary syndrome,
and stroke compared with people of the same age with
normal or mildly reduced eGFR.18,19 With timely specialist
referral and initiation of dialysis, patients with advanced
CKD may benefit from longer survival, better control of
metabolic and electrolyte imbalance, anemia, and lower
risks of cardiovascular events. Therefore, elderly patients
may still benefit from RRT, but there are limited local data
showing to how old of age the benefit preserves. In our
study, a total of 558 patients aged 65 years or older, with
eGFR  15 mL/min/1.73 m2, received ACP for renal treat-
ment. Among these patients, 126 (22.6%) opted for RRT and
432 (77.4%) decided for conservative management. The RRT
group had a significant survival advantage compared with
the conservative group. This survival benefit was preserved
Figure 3 Comparison of KaplaneMeier survival curves for
patients in the conservative and RRT groups, aged < 85 years
and  85 years. ACP Z advance care planning;
Cum Z cumulative; RRT Z renal replacement therapy.
Figure 4 Comparison of KaplaneMeier survival curves for
patients in the conservative and RRT groups with low
(mCCI  6) and high (mCCI  11) comorbidities.
ACP Z advance care planning; Cum Z cumulative;
mCCI Z modified Charlson’s Comorbidity Index; RRT Z renal
replacement therapy.
48 W.-H. Kwok et al.in the older age group (>75 years), but was lost in very old
patients aged  85 years.
Baseline characteristics
Our findings were similar to the study results of Carson and
coworkers,20 Verberne and Bos,21 Murtagh and coworkers,22
which showed that people on dialysis lived significantlylonger than those on conservative management. However,
patients who were managed conservatively were older or
more likely to have high comorbidity. In this study, the
conservative group was also older than the RRT group, with
a higher mCCI score and a higher incidence of congestive
heart failure, stroke, and dementia.
Figure 5 Comparison of KaplaneMeier survival curves for
patients in the conservative and RRT groups with independent
and impaired mobility. ACP Z advance care planning;
Cum Z cumulative; RRT Z renal replacement therapy.
Figure 6 Comparison of KaplaneMeier survival curves for
patients aged 85 years in the conservative and RRT groups
with low mCCI (6) and high mCCI (9) scores. ACPZ advance
care planning; CumZ cumulative; mCCIZmodified Charlson’s
Comorbidity Index; RRT Z renal replacement therapy.
Outcomes in elderly patients with end-stage renal disease 49However, for those who opted for RRT in this study, it
was hard to tell how much of the survival benefit was due
to the treatment modality itself and how much reflected
the selection bias introduced by the selection process it-
self, as the baseline characteristics differed significantly
between the two groups. People choosing RRT were
5 years younger, with lower comorbidity, including a lowerincidence of heart failure and stroke, and a higher pro-
portion were able to walk unaided. Moreover, higher
percentages of people in the RRT group were educated,
with a fully competent mental status, and lived in self-
owned properties and with relatives. This indicated a
better socioeconomic background and family support,
Figure 7 Comparison of KaplaneMeier survival curves for patients in the conservative and RRT groups, who were aged 85 years
and with different functional status. ACP Z advance care planning; Cum Z cumulative; RRT Z renal replacement therapy.
50 W.-H. Kwok et al.which also contribute to the better survival outcomes.
Hussain et al23 and Smith et al24 had also reported that the
conservative group was older, with higher comorbidity and
a poorer performance status (all p < 0.001), compared
with the dialysis group. However, Joly and colleagues25
were unable to show the difference in comorbidity be-
tween the two groups; this might be due to the recruit-
ment of an older age group of >80 years, which already
had uniformly high levels of comorbidity.
Survival of RRT and conservative treatment
In this study, patients who opted for RRT had a significant
survival advantage with a median survival of 44 monthscompared with 10 months in those who opted for conser-
vative management. This survival benefit was preserved in
the older age group of >75 years, but was lost in very old
patients aged 85 years.
Compared with previous studies, our RRT patients had
relatively longer survival probably because of a younger age
of 65 years. Under subgroup analysis, the median survival
of both RRT and conservative group patients decreased with
age. At age 75 years, the median survivals were
32.7 months and 9.1 months, respectively, in the RRT and
conservative groups. At age 85 years, the median sur-
vivals decreased to 11.7 months and 5.0 months, respec-
tively. The 1-year and 2-year survival rates of the RRT group
versus the conservative group at age 65e75 years were
Figure 8 KaplaneMeier survival curves for unaided walkers of different ages in the conservative and RRT groups. ACPZ advance
care planning; Cum Z cumulative; RRT Z renal replacement therapy.
Outcomes in elderly patients with end-stage renal disease 5187.0% versus 48.2% and 65.2% versus 15.2%, respectively.
However, the survival rate declined in older age. At age
75 years, it was 66.7% versus 36.3% and 38.6% versus 11.9%
respectively. Munshi et al26 followed 638 patients on RRT
for 8 years, in which they reported a similar 1-year survival
rate of 53.5% in those aged 75 years, and the 5-year
survival rate was 2.4%. Withdrawal from dialysis was
the most common cause of death (38%), followed by car-
diovascular causes (24%) and infections (22%).26 Joly and
colleagues25 followed 101 dialysis and 43 nondialysis pa-
tients aged 80 years. Survival was measured from
eGFR< 10 mL/min for 12 years. The median survival was
28.9 months in the dialysis group and 8.9 months in the
conservative group (p < 0.001). The 1-year and 2-year
survival rates were 73.6% and 60% in patients treated bydialysis, versus 29% and 15% for patients treated conser-
vatively. Sixty percent patients of the dialysis group and
88.4% of the conservative group died by the end of the
study. These survival outcomes were quite similar to what
we identified in our study, but the patients selected in our
study had a higher eGFR of 15 mL/min.
Apart from very old age of 85 years, in patients with a
high mCCI score of 11 or poor mobility (who were chair-
bound/bedridden), RRT had also lost its survival advan-
tages. However, the survival benefit was preserved even at
an older age of 85 years for patients with independent
mobility, but was lost in all age groups for patients with
poor mobility (i.e. chairbound/bedridden patients). Hus-
sain et al23 also reported a reduction in the survival
advantage in patients older than 80 years, with a high CCI
Figure 9 KaplaneMeier survival curves for chairbound patients of different ages in the conservative and RRT groups.
ACP Z advance care planning; Cum Z cumulative; RRT Z renal replacement therapy.
52 W.-H. Kwok et al.score >8 and a World Health Organization performance
score of 3 or more between dialysis and conservative
groups. This suggested that dialysis might not outweigh
conservative management for those with very old age, high
comorbidity, and a poor functional status.
Factors associated with survival in RRT and
conservative groups
Geriatric patients are more prone to suffering from a va-
riety of functional inconveniences and comorbidities. In
this study, mCCI, functional status, as well as age were
predictors of survival in the RRT group. This suggested that
dialysis patients who were younger, and had a lower mCCIscore and independent functional status were more likely
to have better survival outcomes. However, mCCI did not
predict mortality in the conservative group, but female
patients had a 35% risk reduction in mortality in this group.
Chandna and coworkers27 reported similar findings, showing
that mortality increased with age, high comorbidity, and
diabetes mellitus in both dialysis and conservative groups.
They also showed that female patients had a reduced risk
compared with their male counterparts in the conservative
group. In a Japanese study on PD patients aged 65 years,
it was also demonstrated that a high mCCI score correlated
with reduced patient survival and technique survival.
However, this difference was observed only in patients
aged 70 years and above, but not in those aged between
Figure 10 Comparison of KaplaneMeier survival curves for
independent walkers with different mCCI scores in the con-
servative and RRT groups. ACP Z advance care planning;
Cum Z cumulative; mCCI Z modified Charlson’s Comorbidity
Index; RRT Z renal replacement therapy.
Figure 11 Comparison of KaplaneMeier survival curves for
chairbound patients with different mCCI scores in the conser-
vative and RRT groups. ACP Z advance care planning;
Cum Z cumulative; mCCI Z modified Charlson’s Comorbidity
Index; RRT Z renal replacement therapy.
Outcomes in elderly patients with end-stage renal disease 5365 years and 69 years.28 In two local studies on outcomes of
CAPD patients younger or older than 65 years, there were
no significant survival differences between the two age
groups, but a poorer survival outcome was reported in
those who had diabetes mellitus or required assisted CAPD,
which may indicate more dependent functional status.29,30
However, diabetes mellitus and ischemic heart disease did
not significantly affect the survival outcomes in both the
RRT and the conservative group in our study.Choosing between RRT and conservative
management
In our study, patients aged over 65 years with CKD Stage 5
who opted for RRT had a survival advantage. However, this
survival benefit decreased with age, a high mCCI score, and
a poor functional status. It is reasonable to consider dialysis
as an appropriate treatment option for well-informed
elderly patients with good baseline physical and
Table 3 Cox proportional hazards model for predictors of
mortality in the RRT group.
Predictors of mortality in
the RRT group
Hazard ratio
(95% CI)
p
Age (y) 1.05 (1.00e1.10) 0.03
mCCI 1.12 (1.01e1.24) 0.04
Mobility (independent walker) 0.17 (0.07e0.40) <0.001
CI Z confidence interval; mCCI Z modified Charlson’s Comor-
bidity Index; RRT Z renal replacement therapy.
Table 4 Cox proportional hazards model for predictors of
mortality in the conservative treatment group.
Predictors of mortality in
the conservative group
Hazard ratio
(95% CI)
p
Age 1.02 (1.00e1.03) 0.04
Mobility (independent walker) 0.14 (0.07e0.26) <0.001
Mobility (chairbound/bedridden) 0.29 (0.15e0.56) <0.001
Sex 0.65 (0.53e0.80) <0.001
CI Z confidence interval.
54 W.-H. Kwok et al.functional statuses. On the contrary, conservative man-
agement should be considered as an alternative in very old
patients with high comorbidities and a more dependent
functional status, given that dialysis does not improve
clinical outcomes. Smith and colleagues24 reported that
patients who opted for palliative therapy was more func-
tionally impaired, older, and more likely to have diabetes.
For those patients who were recommended for the con-
servative pathway by the nephrologist, but who opted for
and treated by dialysis, the median survival after dialysis
initiation was not significantly longer than survival in those
who were recommended for conservative management and
agreed not to have dialysis (8.3 months vs. 6.3 months).
However, these groups had a relatively small number of
patients (n Z 10 and 26), making a definitive conclusion
difficult. When the functional status is lower at baseline,
initiation of dialysis may signal the onset of further de-
clines. In a US cohort of 3702 nursing home residents initi-
ating dialysis, who already had a relatively lower functional
baseline, functional status had been maintained in only 39%
of them 3 months after initiation of dialysis. Among these
patients, 58% had died and 87% had experienced additional
loss of function by 1 year after the initiation of dialysis.31
The North Thames Dialysis Study reported similar findings
that the physical quality of life of patients aged 70 years
was significantly lower 3 months after the initiation of
dialysis. However, the mental quality of life remained
similar to that of the general UK or US population. It also
reported that the survival rate declined with increasing age
(1-year survival rate: 80% in patients aged 70e74 years and
54% in those aged  80 years as well as high comorbidity
(88% in those with no comorbidity and 64% with 2 or more
comorbidities).32
The decision to commence dialysis or to have conser-
vative management is complex for each patient.Conservative management is not simply defined as “no
dialysis”; it includes active disease management (e.g.,
management of anemia) and detailed supportive care,
which become increasingly complex toward the end of
life.33e35 Survival duration, disease and treatment burden
of dialysis, anticipated quality of life with or without dial-
ysis, and patient preferences, all play an important part in
making a decision for or against dialysis. The decision
making becomes more challenging in elderly patients not
simply because age itself precludes dialysis, but because of
consideration of comorbidity, reduced overall life expec-
tance, and the impact of dialysis on quality of life and
patient’s life style. With increasing age, this becomes more
complex.22,36 Morton and colleagues37 demonstrated in a
thematic analysis that awareness of factors associated with
decision making for treatment plan in chronic renal failure
patients can be classified in four themesdconfronting
mortality (choosing life or death, burden on family, and
state of limbo), lack of choice (medical decision, lack of
information, and constraints on resources), knowledge of
options (peer influence and timing of information), and
weighing the alternatives (maintaining lifestyle, family in-
fluence, and the status quo). Decision making of patients
and caregivers are greatly influenced by the experiences of
other patients and nephrologist’s opinion. Furthermore, the
preference to maintain the status quo may be the reason
why patients often remain on their initial therapy.
In elderly renal failure patients, prognostication and
decision making regarding commencing dialysis or not
remain difficult and should be individualized.38,39 When
planning for long-term dialysis, it is important to respect
the needs and rights of elderly patients and to maintain
their ability of self-care for better outcome.29 Collabo-
ration between nephrology team, palliative care team,
geriatricians, social workers, dietitians, occupational
therapists, and physiotherapists is important for multi-
disciplinary and multifactorial assessment and interven-
tion to assist in decision making in older patients with
Stage 5 CKD.Limitations of the study
This study had a number of limitations. First, this study was
conducted in a single center, which posed a limitation of
generalization of the results. Besides, this was a retro-
spective study; the data collected depended on the docu-
mentation of attending physician and social worker during
ACP and follow ups. Third, randomization of patients to
dialysis or conservative management is unethical. Fourth,
selection bias might be present in this study, as older adults
with good physical and mental functioning, low comorbid-
ity, or strong family support might be more likely to be
referred for ACP assessment. Meanwhile, those who lived in
a nursing home and were of very old age, with worse
functional and mental statuses and high comorbidity, were
usually followed up by the Community Geriatric Assessment
Team. Their decisions for conservative management were
often made between the Community Geriatric Assessment
Team doctor and the patient or family, and were less likely
to be referred to the ACP assessment. There were no data
on the percentage of these missing patients. Fifth, the
Outcomes in elderly patients with end-stage renal disease 55number of patients aged above 85 years was relatively
small, with only 89 patients in the conservative group and
seven in the RRT group. The number of patients was even
smaller when they were divided into subgroups according to
their mobility and mCCI scores. This may make a definite
conclusion in this subgroup analysis difficult; we should
treat this with reservation. Lastly, symptom burden, quality
of life, and functional outcomes were not assessed in this
study. Future large prospective cohort studies investigating
these factors in addition to survival of older people
receiving dialysis versus conservative management are
warranted.
Conclusion
Although age affects outcomes of dialysis, old age alone
is not an absolute contraindication to dialysis. This study
has contributed to our understanding of the prognosis in
older patients with Stage 5 CKD treated by RRT or con-
servative management. A significant survival benefit
could be observed in older patients receiving dialysis.
However, survival advantages of dialysis were lost in pa-
tients of very advanced age who were older than
85 years, in those with high comorbidity, or in more
functionally dependent patients. In these patients, con-
servative management is a reasonable alternative. While
our results contribute to the information that can guide
patients in making a treatment decision, an individual-
ized approach to decision making is mandatory, in respect
of individual’s needs and rights.
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